These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide. Yang J; Guo H; Padilla RS; Berwick M; Miao Y Bioorg Med Chem; 2010 Sep; 18(18):6695-700. PubMed ID: 20728365 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties. Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084 [TBL] [Abstract][Full Text] [Related]
4. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake. Yang J; Hu CA; Miao Y Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy. Yang J; Guo H; Gallazzi F; Berwick M; Padilla RS; Miao Y Bioconjug Chem; 2009 Aug; 20(8):1634-42. PubMed ID: 19552406 [TBL] [Abstract][Full Text] [Related]
6. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties. Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429 [TBL] [Abstract][Full Text] [Related]
7. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma. Cheng Z; Chen J; Quinn TP; Jurisson SS Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076 [TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting. Chen J; Giblin MF; Wang N; Jurisson SS; Quinn TP Nucl Med Biol; 1999 Aug; 26(6):687-93. PubMed ID: 10587108 [TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy. Miao Y; Owen NK; Whitener D; Gallazzi F; Hoffman TJ; Quinn TP Int J Cancer; 2002 Oct; 101(5):480-7. PubMed ID: 12216078 [TBL] [Abstract][Full Text] [Related]
11. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection. Miao Y; Benwell K; Quinn TP J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701 [TBL] [Abstract][Full Text] [Related]
12. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues. Cheng Z; Chen J; Miao Y; Owen NK; Quinn TP; Jurisson SS J Med Chem; 2002 Jul; 45(14):3048-56. PubMed ID: 12086490 [TBL] [Abstract][Full Text] [Related]
13. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection. Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404 [TBL] [Abstract][Full Text] [Related]
14. Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides. Yang J; Lu J; Miao Y Mol Pharm; 2012 May; 9(5):1418-24. PubMed ID: 22452443 [TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model. Miao Y; Hoffman TJ; Quinn TP Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues. Miao Y; Whitener D; Feng W; Owen NK; Chen J; Quinn TP Bioconjug Chem; 2003; 14(6):1177-84. PubMed ID: 14624632 [TBL] [Abstract][Full Text] [Related]
17. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases. Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683 [TBL] [Abstract][Full Text] [Related]
18. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo. Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062 [TBL] [Abstract][Full Text] [Related]
19. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog. Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880 [TBL] [Abstract][Full Text] [Related]
20. Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides. Flook AM; Yang J; Miao Y J Med Chem; 2014 Nov; 57(21):9010-8. PubMed ID: 25290883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]